BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32016632)

  • 1. Comparison of Hepatic Resection Combined with Intraoperative Radiofrequency Ablation, or Hepatic Resection Alone, for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the University of California San Francisco (UCSF) Criteria: A Propensity Score-Matched Analysis.
    Huang Y; Song J; Zheng J; Jiang L; Yan L; Yang J; Zeng Y; Wu H
    Ann Surg Oncol; 2020 Jul; 27(7):2334-2345. PubMed ID: 32016632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living donor liver transplantation or hepatic resection combined with intraoperative radiofrequency ablation for Child-Pugh A hepatocellular carcinoma patient with Multifocal Tumours Meeting the University of California San Francisco (UCSF) criteria.
    Xu X; Pu X; Jiang L; Huang Y; Yan L; Yang J; Wen T; Li B; Wu H; Wang W
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):607-618. PubMed ID: 32852635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Outcomes of Hepatic Resection and Radiofrequency Ablation for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the Barcelona-Clinic Liver Cancer Stage A Classification.
    Jiang L; Yan L; Wen T; Li B; Zeng Y; Yang J; Wang W; Xu M; Wu H
    J Am Coll Surg; 2015 Nov; 221(5):951-61. PubMed ID: 26362135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Resection Combined with Intraoperative Radiofrequency Ablation Versus Hepatic Resection Alone for Selected Patients with Moderately Advanced Multifocal Hepatocellular Carcinomas.
    Zheng K; Liao A; Yan L; Yang J; Wen T; Wang W; Li B; Wu H; Jiang L
    Ann Surg Oncol; 2022 Aug; 29(8):5189-5201. PubMed ID: 35441310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeat hepatic resection combined with intraoperative radiofrequency ablation versus repeat hepatic resection alone for recurrent and multiple hepatocellular carcinoma patients meeting the Barcelona Clinic Liver Cancer stage A: A propensity score-matched analysis.
    Huang Y; Xu L; Huang M; Jiang L; Xu M
    Cancer Med; 2023 Apr; 12(8):9213-9227. PubMed ID: 36722129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation versus surgical resection for multiple HCCs meeting the Milan criteria: propensity score analyses of 10-year therapeutic outcomes.
    Min JH; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Sinn DH; Kim JM; Sohn I
    Clin Radiol; 2018 Jul; 73(7):676.e15-676.e24. PubMed ID: 29709236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small masses (≤3 cm) diagnosed as hepatocellular carcinoma on pre-treatment imaging: comparison of therapeutic outcomes between hepatic resection and radiofrequency ablation.
    Cha DI; Song KD; Kang TW; Lee MW; Rhim H
    Br J Radiol; 2020 Jan; 93(1105):20190719. PubMed ID: 31670571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
    Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined resection and radiofrequency ablation versus transarterial embolization for intermediate-stage hepatocellular carcinoma: A propensity score matching study.
    Espinosa W; Liu YW; Wang CC; Lin CC; Wang JH; Lu SN; Hung CH
    J Formos Med Assoc; 2018 Mar; 117(3):197-203. PubMed ID: 28411877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysis.
    Xu LL; Zhang M; Yi PS; Zheng XB; Feng L; Lan C; Tang JW; Ren SS; Xu MQ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):974-980. PubMed ID: 29270762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomic resection versus radiofrequency ablation with an ablative margin ≥ 1.0 cm for solitary small hepatocellular carcinoma measuring ≤ 3 cm: Comparison of long-term outcomes using propensity score matching analysis.
    Zhang C; Gao R; Guo S; Ning C; Li A; Wang X; Li S; Ding J; Kong X; Wang Q; Xu Y; Li J; Gao J; Wang S; Kong J; Ke S; Sun W
    Eur J Radiol; 2022 Oct; 155():110498. PubMed ID: 36049409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan.
    Wu CC; Tseng CW; Tseng KC; Chen YC; Wu TW; Chang SY; Chang YJ; Chao YC; Hsu CS
    J Formos Med Assoc; 2021 May; 120(5):1249-1258. PubMed ID: 33288401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic Hepatic Resection Versus Laparoscopic Radiofrequency Ablation for Subcapsular Hepatocellular Carcinomas Smaller Than 3 cm: Analysis of Treatment Outcomes Using Propensity Score Matching.
    Ko SE; Lee MW; Ahn S; Rhim H; Kang TW; Song KD; Kim JM; Choi GS; Cha DI; Min JH; Sinn DH; Choi MS; Lim HK
    Korean J Radiol; 2022 Jun; 23(6):615-624. PubMed ID: 35289151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery.
    Chen S; Peng Z; Xiao H; Lin M; Chen Z; Jiang C; Hu W; Xie X; Liu L; Peng B; Kuang M
    Int J Hyperthermia; 2018 Nov; 34(7):1029-1037. PubMed ID: 28974113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas.
    Kim GA; Shim JH; Kim MJ; Kim SY; Won HJ; Shin YM; Kim PN; Kim KH; Lee SG; Lee HC
    Br J Surg; 2016 Jan; 103(1):126-35. PubMed ID: 26572697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort.
    Kaibori M; Yoshii K; Hasegawa K; Ogawa A; Kubo S; Tateishi R; Izumi N; Kadoya M; Kudo M; Kumada T; Sakamoto M; Nakashima O; Matsuyama Y; Takayama T; Kokudo N;
    Ann Surg; 2019 Jul; 270(1):121-130. PubMed ID: 29608544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    He W; Li B; Zheng Y; Zou R; Shen J; Cheng D; Tao Q; Liu W; Li Q; Chen G; Yuan Y
    Liver Int; 2016 Nov; 36(11):1677-1687. PubMed ID: 27187721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Uhlig J; Sellers CM; Stein SM; Kim HS
    Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.